# Heerkang Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/heerkang-medical-technology

- Industry: Healthcare IT
- Headquarters: Chengdu, China
- Latest round: Series A (Aug 12, 2025)
- Investors on record: 3

## About

Established in 2024 and based in Chengdu, China, Heerkang Medical Technology is a medical health company that focuses on research and development of related software platforms in the field of chronic diseases. In August 2025, Heerkang Medical Technology raised a series A funding led by new investor Huaige Capital, with participation from new investors BIO-TOWN Capital and CDHT Hi-Tech Venture.

The company has self-developed products include diabetes management system DMS and hypertension management system HMS. 

The company generates revenue through the sale of software platforms and other related products. 

The funding raised in August 2025 will be used to further enhance its technology portfolio, promote the intelligent upgrade of chronic disease management services, and expand the platform's application depth and breadth in the diabetes and hypertension fields.

## Funding rounds

- Series A, Aug 12, 2025 — CDHT Hi-Tech Venture, Huaige Capital, BIO-TOWN Capital

## Investors

- CDHT Hi-Tech Venture (https://capitalatlas.ai/funds/cdht-hi-tech-venture) — Series A
- Huaige Capital (https://capitalatlas.ai/funds/huaige-capital) — Series A
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Series A